05.08.2020 | Original Article | Ausgabe 3/2020
Open Access
Effect of high-fat diet on the pharmacokinetics and safety of flumatinib in healthy Chinese subjects
Yun Kuang, Hui-ling Song, Guo-ping Yang, Qi Pei, Xiao-yan Yang, Ling Ye, Shuang Yang, Shu-ting Wu, Can Guo, Qing-nan He, Jie Huang
08.08.2020 | Original Article | Ausgabe 3/2020
Open Access
Asian race and origin have no clinically meaningful effects on polatuzumab vedotin pharmacokinetics in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
Rong Shi, Tong Lu, Grace Ku, Hao Ding, Tomohisa Saito, Leonid Gibiansky, Priya Agarwal, Xiaobin Li, Jin Yan Jin, Sandhya Girish, Dale Miles, Chunze Li, Dan Lu
10.08.2020 | Original Article | Ausgabe 3/2020
Open Access
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway
Marianna Lucafò, Daria Sicari, Andrea Chicco, Debora Curci, Arianna Bellazzo, Alessia Di Silvestre, Chiara Pegolo, Robert Autry, Erika Cecchin, Sara De Iudicibus, Licio Collavin, William Evans, Giuliana Decorti, Gabriele Stocco
20.08.2020 | Original Article | Ausgabe 3/2020
Neutropenia is an indicator of outcomes in metastatic colorectal cancer patients treated with FTD/TPI plus bevacizumab: a retrospective study
Yohei Nose, Yoshinori Kagawa, Taishi Hata, Ryota Mori, Kenji Kawai, Atsushi Naito, Takuya Sakamoto, Kohei Murakami, Yoshiteru Katsura, Yoshiaki Ohmura, Toru Masuzawa, Atsushi Takeno, Yutaka Takeda, Takeshi Kato, Kohei Murata
